Why is this ASX 200 healthcare share jumping 7% today?

This healthcare share is getting a lot of love from investors today.

| More on:
Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Ltd (ASX: RHC) share price is having a strong session on Wednesday.

In morning trade, the ASX 200 healthcare share is up 7% to $58.68.

Why is this ASX 200 healthcare share racing higher?

Investors have been bidding Ramsay Health Care shares higher today after the private hospital operator released a couple of announcements.

The first announcement reveals that the company is looking to offload its 50% owned Ramsay Sime Darby Health Care (RSD) joint venture in Asia.

The release notes that the decision was made following the receipt of significant inbound interest in RSD at values that it feels are in shareholders' interests to explore. Though, it warns that there is no certainty that a sale process will result in a completed transaction.

Ramsay also revealed that the business continues to perform strongly, with its equity accounted contribution for the 9 months to 31 March 2023 up 31.7% to $16.2 million.

What else?

A second announcement reveals that the ASX 200 healthcare share has refinanced its bank loan facilities.

According to the release, the company has secured $1.5 billion in new committed revolving bank loan facilities with two of its key relationship banks.

The facilities, which will mature in FY 2026, are part of Ramsay Health Care's ongoing bank loan refinancing activities. They will be used to repay facilities maturing in FY 2025.

Management also advised that it will continue to seek to diversify the source and tenor of its borrowings over time.

While today's gain is of course good news for shareholders, it does not change much for them on a 12-month basis. Since this time last year, the ASX 200 healthcare share has lost almost 21% of its value.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two happy scientists analysing test results.
52-Week Highs

3 ASX All Ords health care shares that reached 52-week peaks today

These health care companies finished the week on a positive note.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

2 ASX healthcare shares rocketing over 16% on Big US news

These companies are making their shareholders smile on Thursday. But why?

Read more »

Shot of a young scientist looking stressed while conducting medical research in a laboratory.
Healthcare Shares

Should you buy CSL shares after recent weakness?

Does the dip present a buying opportunity?

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Sigma shares up 25% in 2 days as Chemist Warehouse merger looks set

The deal continues to create tailwinds for Sigma shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Healthcare Shares

500 million reasons why ResMed shares are charging higher today

This growing company has big plans and is forecasting strong growth through to the end of the decade.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

'Exciting prospect': 2 ASX pharmaceutical shares to keep a close eye on

These companies have developed new drugs to treat vision loss and erectile dysfunction.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Guess which ASX 200 healthcare stock is up 12% on big Chemist Warehouse news

Investors appear to believe this news could be a sign that the deal will go ahead.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Healthcare Shares

Up 630% this year AND profitable! This small ASX healthcare share is glowing

Why has this stock delivered incredible returns this year? Let's find out.

Read more »